Form 4: CompoSecure Executive Adam Lowe Exercises Stock Options, Acquires Shares
SEC Form 4 Filing
Adam Lowe, Chief Product & Innovation Officer at CompoSecure, exercised stock options to acquire 113,522 shares of Class A common stock on May 16, 2024.
Summary
- On May 16, 2024, Adam Lowe, the Chief Product & Innovation Officer of CompoSecure, Inc., exercised stock options.
- This transaction resulted in the acquisition of 113,522 shares of Class A common stock at a price of $0.01 per share.
- 114,323 shares from the option were withheld to cover the exercise price of the option and related taxes.
- Following the transaction, Lowe directly owns 113,522 shares of Class A Common Stock.
- The option exercise was conducted under the CompoSecure, L.L.C. Amended and Restated Equity Incentive Plan.
- All shares subject to the option were fully vested and exercisable as of the transaction date.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of an executive exercising stock options. It doesn't inherently indicate positive or negative sentiment, but rather a routine transaction.
Positives
- The exercise of vested options by a company executive can be seen as a sign of confidence in the company's future prospects.
Future Outlook
There is no future outlook provided in this document.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| 05/16/2024 | Date of the stock option exercise and acquisition of shares. |
| 05/15/2025 | Expiration date of the stock option. |
| 05/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.